| Patient | Sir John Franklin |
|---|---|
| Date of birth | 1967-04-16 |
| Identifiers | MRN HR-EX005-SYN; SSN (made up) 000-05-3328 |
| Document date | 2026-02-24 |
| Author | Cordelia Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-week review after starting amlodipine, two weeks after influenza. [S]
Sir John has taken amlodipine 5 mg every morning for four weeks. Two weeks ago he had influenza A, treated with five days of oseltamivir; the fever settled in three days, and he is left with a dry cough on cold mornings and tires earlier than usual on his walks, though he is walking two to three miles again. His home readings for the past week average 134/84. He has no ankle swelling, dizziness or flushing. He has lost 1.8 kg since intake. He had his echocardiogram this morning and brought a urine sample. His exercise treadmill test, booked for today, was postponed at the sick visit until he has been back to his usual activity for two weeks. [S]
| Element | Detail |
|---|---|
| Home readings | Seven-day average 134/84 mmHg |
| Influenza | Recovering; dry morning cough; tires earlier |
| Amlodipine | No side effects |
| Echocardiogram | Ejection fraction 62%; mild concentric remodeling |
| Urine albumin-to-creatinine ratio | 12 mg/g |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tires earlier than usual since influenza |
| Respiratory | Positive | Dry cough on cold mornings; no breathlessness or sputum |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Neurological | Negative | No dizziness |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet once daily | One tablet by mouth every morning | Oral route | 2026-01-27 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar winters | One tablet by mouth daily | Oral route | 2026-01-27 | active | S |
| Oseltamivir 75 mg oral capsule twice daily for five days | One capsule by mouth twice a day for five days | Oral route | 2026-02-10 to 2026-02-14 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-24 | Body height | 170 | cm | S |
| 2026-02-24 | Body weight | 89 | kg | S |
| 2026-02-24 | Body mass index (BMI) [Ratio] | 30.8 | kg/m2 | S |
| 2026-02-24 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-02-24 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-02-24 | Heart rate | 80 | /min | S |
| 2026-02-24 | Respiratory rate | 16 | /min | S |
| 2026-02-24 | Body temperature | 36.7 | Cel | S |
| 2026-02-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-24 | Albumin/Creatinine [Mass Ratio] in Urine | 12 | mg/g | Below 30 mg/g normal | Normal | S |
| 2026-02-24 | Left ventricular Ejection fraction | 62 | % | 52-72% | Normal | S |
Vital signs recorded on 2026-02-24; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; afebrile; blood pressure 136/84, pulse 80; weight 89.0 kg, BMI 30.8 |
| Respiratory | Clear to auscultation |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension. |
| Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; synthetic | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded. |
| Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and food | active | confirmed | E66.811 | S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded. |
| Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation plan | active | confirmed | Z71.84 | S — Synthetic travel-health problem anchored to the documented expedition. |
| Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy rooms | active | confirmed | H83.3X3 | S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic. |
| Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness ahead | active | confirmed | E55.9 | S — Synthetic laboratory finding at intake. |
| Influenza A, confirmed by rapid molecular test, with fever, cough and aches, without pneumonia; treated with oseltamivir; recovered with a lingering cough | resolved | confirmed | J10.1 | S — Synthetic modern illness anchored to the documented severe influenza of the winter before the expedition; the test, course and treatment are synthetic. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure (seated, five minutes' rest, large cuff, average of two readings) | Every visit | Completed today | 136/84 mmHg |
| Self-management | Home blood pressure monitoring | At diagnosis and two to four weeks after each treatment change, then weekly | Completed today | Average 134/84 mmHg four weeks after starting amlodipine |
| Examination | Weight, BMI and waist | Every visit | Completed today | 89.0 kg, BMI 30.8 |
| Examination | Cardiac auscultation | Every visit | Completed today | No murmur or gallop |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Completed today | 12 mg/g, normal; the sample deferred from intake |
| Laboratory | Basic metabolic panel, potassium and eGFR | Yearly (every six months only on a diuretic or renin-angiotensin blocker) | Up to date | Not needed for amlodipine; yearly |
| Imaging | Echocardiogram | At diagnosis of stage 2 hypertension or suspected left ventricular hypertrophy | Completed today | Ejection fraction 62%; mild concentric remodeling, septum 11 mm; normal valves |
| Medication safety | Amlodipine safety: ankle swelling, dizziness, flushing | At each visit | Completed today | No ankle swelling, dizziness or flushing |
| Examination | Exercise treadmill test before strenuous remote work | Before clearance | Due | Postponed at the sick visit until two weeks of usual activity after influenza; rebooked for the eight-week review |
| Referral | Wilderness and expedition medicine consultation | Before clearance for remote duty | Up to date | Seen four weeks ago |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and hyperlipidemia monographs (2026); Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions (2018); Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza (2018)
Follow-up: Preventive visit with vaccinations in two weeks. Eight-week review with the exercise treadmill test. Call for breathlessness or a worsening cough. Next scheduled visit 2026-03-10: periodic adult preventive visit. [S]